EXHIBIT 10.7 Collaborative Research Agreement This agreement dated as of November 1, 2001 between Pfizer Inc, a Delaware corporation, having a principal place of business at 235 E 42nd Street, New York, New York 10017 and its Affiliates ("Pfizer") and...Collaborative Research Agreement • November 17th, 2003 • Exten Industries Inc • Surgical & medical instruments & apparatus • New York
Collaborative Research Agreement (Draft)Collaborative Research Agreement • March 30th, 2018
The University of [ ] (the “University”) and [Company Name] (the “Collaborator”) enter into this Collaborative Research Agreement (this “Agreement”) to conduct the collaborative research (the “Collaborative Research”) set out in the Agreement Particulars as follows.
THE NAME OF INSTITUTECollaborative Research Agreement • May 13th, 2022
Collaborative Research AgreementCollaborative Research Agreement • June 15th, 2021
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • October 24th, 2020
THIS COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”) is made and entered into effective as of [MONTH] [DAY], [YEAR] by and between KEIO UNIVERSITY, having its principal place of business at 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan (“University”), and [NAME OF COUNTERPARTY], having its principal place of business at [ADDRESS] (the “Company”). Each of University and Company may be referred to herein individually as a “Party” or collectively as the “Parties.”
Collaborative Research AgreementCollaborative Research Agreement • December 1st, 2020
Collaborative Research AgreementCollaborative Research Agreement • December 25th, 2020
The University of Tokyo (the “University”) and [Company Name] (the “Partner”; the University and the Partner being collectively referred to as the “Parties” and each individually a “Party”) enter into this Collaborative Research Agreement (this “Agreement”) on the terms and conditions defined in the Terms and Conditions of Agreement attached to this Agreement, to conduct the collaborative research (the “Collaborative Research”) set out in the Agreement Particulars as follows.
SCHERING-PLOUGH RESEARCH INSTITUTECollaborative Research Agreement • June 30th, 1998 • Abgenix Inc • Biological products, (no disgnostic substances) • California
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • June 30th, 2020 • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
COLLABORATIVE RESEARCH AGREEMENT AND ALLOCATION OF RIGHTS IN INTELLECTUAL PROPERTY UNDER A STTR RESEARCH PROJECTCollaborative Research Agreement • May 5th, 2020 • Wisconsin
This Agreement between (hereinafter “Company”), a business concern having an address at __________________________________________________________ ___________________________________________ and the University of Wisconsin – Madison (hereinafter the “University”), a university having a place of business at 21 N. Park Street, Suite 6401, Madison, Wisconsin, WI 53715-1218, is entered into for the purpose of allocating between the parties certain rights relating to a STTR research project to be carried out by Company and the University (hereinafter referred to as a “Party” or the “Parties”) under a STTR funding agreement that may be awarded by ________________________________________________________________________________________ (hereinafter the “Agency”) to Company to fund a proposal dated ___________________ and entitled __________________________________________________________________________________ _________________________________________________________________ (the “STTR Propos
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • December 13th, 2022 • New York
THIS AGREEMENT is made as of ________, 2016, by and between the University of Rochester, an educational institution chartered by the State of New York and a business office located at the, 500 Joseph C. Wilson Blvd. RC Box 270140, Rochester, New York 14627-0001 (“University”) and __________________, a [state of incorporation] corporation having its principal place of business at _________________ ("Collaborator").
For Non-Corporate Counterparty] COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • December 2nd, 2019
THIS COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”) is made and entered into effective as of [MONTH] [DAY], [YEAR] by and between KEIO UNIVERSITY, having its principal place of business at 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan (“Keio”), and [NAME OF COUNTERPARTY], having its principal place of business at [ADDRESS] (the “Counterparty”). Each of Keio and Counterparty may be referred to herein individually as a “Party” or collectively as the “Parties.”
Collaborative Research Agreement (Draft)Collaborative Research Agreement • March 29th, 2017
The University of [ ] (the “University”) and [Company Name] (the “Collaborator”) enter into this Collaborative Research Agreement (this “Agreement”) to conduct the collaborative research (the “Collaborative Research”) set out in the Agreement Particulars as follows.
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • May 3rd, 2004 • Xenogen Corp • Services-commercial physical & biological research • New Jersey
This COLLABORATIVE RESEARCH AGREEMENT (“Agreement”) is entered into as of September 30,2001 by and between PFIZER INC, a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017 and its Affiliates (“Pfizer”), and XENOGEN BIOSCIENCES (“Xenogen Cranbury”), an Ohio Corporation, with an office at 5 Cedar Brook Drive, Cranbury, NJ 08512, and a wholly owned subsidiary of Xenogen Corp. (“Xenogen”).
COLLABORATIVE RESEARCH AGREEMENT BETWEENCollaborative Research Agreement • June 25th, 2018
THIS COLLABORATIVE RESEARCH AGREEMENT (hereinafter “Agreement”) is entered into by and between Pfizer Inc., a Delaware corporation having an office at 235 East 42nd Street, New York, New York 10017 (“Pfizer”); and Academic Medical Center, a [TYPE OF INSTITUTION] having an office at [INSERT ADDRESS] (hereinafter “AMC”) for the conduct of collaborative preclinical and clinical research studies in the area of identification and testing of new disease indications for existing Pfizer drug candidates.
COLLABORATIVE RESEARCH AGREEMENT between McMaster University 1280 Main Street West Hamilton, Ontario L8S 4L8 and [Name and Address of Company]Collaborative Research Agreement • December 14th, 2022
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • February 21st, 2022
THIS COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”), effective as of the _____ day of ______, 20__ (the “Effective Date”), is made by and between Hiroshima University, a national university corporation duly organized under the laws of Japan, having a principal address at 1-3-2 Kagamiyama, Higashi-Hiroshima City, Hiroshima Pref., 739-8511, Japan (“University”), and [XYZ Corporation], a corporation duly organized under the laws of ______, having a principal place of business at ___________________, (“XYZ”).
AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • January 14th, 2010 • Codexis Inc • Industrial organic chemicals • New York
THIS AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT, together with exhibits and schedules attached hereto, (the “Amended and Restated Research Agreement” or the “Agreement”) is entered into as of the Execution Date and effective as of November 1, 2006 (the “Effective Date”), by and between Equilon Enterprises LLC dba Shell Oil Products US, a Delaware limited liability company, having a place of business at 910 Louisiana Street, Houston, Texas 77002 (“Shell”), and Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063 (“Codexis”). Shell and Codexis may each be referred to herein individually as a “Party” or, collectively, as the “Parties.”
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • June 30th, 2020 • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
Collaborative Research Agreement (Draft)Collaborative Research Agreement • March 29th, 2017
The University of [ ] (the “University”) and [Company Name] (the “Collaborator”) enter into this Collaborative Research Agreement (this “Agreement”) to conduct the collaborative research (the “Collaborative Research”) set out in the Agreement Particulars as follows.
EX-10.13 3 a2234645zex-10_13.htm EX-10.13 COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • May 5th, 2020 • New York
THIS COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”) is made and entered into as of August 27th, 2017 (“Effective Date”) between BIOXCEL THERAPEUTICS, INC., a Delaware corporation, having its principal place of business at 780 East Main Street, Branford, CT 06405 (“BTI”) and NEKTAR THERAPEUTICS, a Delaware corporation, having its principal place of business at 455 Mission Bay Boulevard South, San Francisco, CA 94158 (“Nektar”). Each of Nektar and BTI may be referred to herein as a “Party” or collectively as the “Parties.”
COLLABORATIVE RESEARCH AGREEMENT BETWEENCollaborative Research Agreement • December 22nd, 2016
THIS COLLABORATIVE RESEARCH AGREEMENT (hereinafter “Agreement”) is entered into by and between [Medical Device Company] a [TYPE OF ENTITY] at [INSERT ADDRESS] (hereinafter “COMPANY”) and [Research Institution], a [TYPE OF INSTITUTION] having an office at [INSERT ADDRESS] (hereinafter “INSTITUTION”) for the conduct of collaborative clinical exploratory research studies utilizing existing COMPANY devices to record and/or stimulate from the central nervous system.
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3 (“UBC”)
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • November 21st, 2016 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS AGREEMENT is made as of April 22, 2016 (“Effective Date”) by and between General Electric Company, acting through its GE Healthcare business and Global Research unit (“GE”), and ENDRA Inc. a Delaware corporation having its principal place of business at Ann Arbor, MI (“ENDRA”).
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • December 22nd, 2021
THIS COLLABORATIVE RESEARCH AGREEMENT (“Agreement”) is made effective as of the last date of execution below (“Effective Date”) by and between:
EXHIBIT 10.5 COLLABORATIVE RESEARCH AGREEMENT This Collaborative Research Agreement (the "Agreement") is made as of the 24th day of March, 1999 ("Effective Date"), by and between Telik, Inc., a Delaware corporation having a place of business at 750...Collaborative Research Agreement • August 7th, 2000 • Telik Inc • Services-commercial physical & biological research • California
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • November 12th, 2020 • Manitoba
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • November 7th, 2016 • AquaBounty Technologies, Inc. • Fishing, hunting and trapping
This COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”) is made and entered into as of March 22, 2012, by and between Aqua Bounty Canada Inc. (the “Company”), a Newfoundland corporation having registered offices at P.O. Box 2430, St. John’s, Newfoundland, Canada, A1C 6E7, and Tethys Aquaculture Canada, Inc. (the “Collaborator”), a Canadian corporation with offices at 0718 Bay Fortune, RR No. 4, Souris, PEI, Canada, C0A 2B0. The Company and the Collaborator are sometimes referred to in this Agreement together as the “Parties” or individually as a “Party.”
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3 (“UBC”)
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • December 19th, 2022
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • April 18th, 2018
[company name], a corporation organized and existing pursuant to the laws of [country] and having its registered office at [address] (“Collaborator”)
University of Wisconsin-Madison Collaborative Research AgreementCollaborative Research Agreement • November 11th, 2020 • Wisconsin
This collaborative research Agreement (Agreement) is entered into on [insert start date] between the Board of Regents of the University of Wisconsin System on behalf of the University of Wisconsin-Madison (University), a public educational institution of the State of Wisconsin, and [insert name] (Collaborator).
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • December 7th, 2016 • ITUS Corp • Patent owners & lessors • Pennsylvania
This COLLABORATIVE RESEARCH AGREEMENT (the “Agreement”) is made as of the 14th day of July, 2015 (the “Effective Date”) by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation (“Wistar”) and ANIXA DIAGNOSTIC CORPORATION, a Delaware corporation (“Collaborator”).
Collaborative Research Agreement (no grant funding)Collaborative Research Agreement • October 30th, 2023
Guidance notes (delete) UNSW INTERNAL USE ONLY When to use (and not to use) this template agreement This UNSW Collaborative Research Agreement (no grant funding) template can be used where UNSW is entering into a collaboration with an external party to conduct a research project. Some primary considerations for the use of this template are noted below: UNSW will be the primary site for the conduct of the research. The template has been drafted as a multi-party agreement but may be modified by appropriately changing the wording where only one external collaborator will be involved. The template contains terms favourable to UNSW (such as UNSW ownership of all Project Intellectual Property (IP)). As UNSW will be the primary site for conduct of the research, the agreement also confers certain responsibilities on UNSW and imposes obligations on the collaborators to minimise UNSW’s exposure to risk in relation to activities onsite. This template does not contain specific provisions covering
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • Michigan
THIS COLLABORATIVE RESEARCH AGREEMENT (“Agreement”), is made the 3rd day of January, 2017 (the “Effective Date”), by and between Celsee Diagnostics, Inc. whose address is 4670l Commerce Center Drive, Plymouth, MI 48170 (“Celsee”) and Zomedica Pharmaceuticals Corp. whose head office address is 3928 Varsity Drive, Ann Arbor, MI 48018 (“Zomedica”) (Celsee and Zomedica are each a “Party” and collectively the “Parties”).
